These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

893 related items for PubMed ID: 28878197

  • 1. Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.
    Ter Horst KW, Serlie MJ.
    Nutrients; 2017 Sep 06; 9(9):. PubMed ID: 28878197
    [Abstract] [Full Text] [Related]

  • 2. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
    Softic S, Cohen DE, Kahn CR.
    Dig Dis Sci; 2016 May 06; 61(5):1282-93. PubMed ID: 26856717
    [Abstract] [Full Text] [Related]

  • 3. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H.
    World J Gastroenterol; 2013 Feb 28; 19(8):1166-72. PubMed ID: 23482247
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G, Legaki AI, Georgila K, Vorkas P, Giannousi E, Stamatakis G, Moustakas II, Petrocheilou M, Pyrina I, Gercken B, Kassi E, Chavakis T, Pateras IS, Panayotou G, Gika H, Samiotaki M, Eliopoulos AG, Chatzigeorgiou A.
    Metabolism; 2023 Jul 28; 144():155552. PubMed ID: 36996933
    [Abstract] [Full Text] [Related]

  • 8. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
    Cohen CC, Li KW, Alazraki AL, Beysen C, Carrier CA, Cleeton RL, Dandan M, Figueroa J, Knight-Scott J, Knott CJ, Newton KP, Nyangau EM, Sirlin CB, Ugalde-Nicalo PA, Welsh JA, Hellerstein MK, Schwimmer JB, Vos MB.
    J Clin Invest; 2021 Dec 15; 131(24):. PubMed ID: 34907907
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fructose drives de novo lipogenesis affecting metabolic health.
    Geidl-Flueck B, Gerber PA.
    J Endocrinol; 2023 May 01; 257(2):. PubMed ID: 36753292
    [Abstract] [Full Text] [Related]

  • 12. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
    Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ.
    J Hepatol; 2018 May 01; 68(5):1063-1075. PubMed ID: 29408694
    [Abstract] [Full Text] [Related]

  • 13. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A, Brandt A, Conzelmann IB, Özel Y, Bergheim I.
    Nutrients; 2018 Sep 19; 10(9):. PubMed ID: 30235828
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review.
    Coronati M, Baratta F, Pastori D, Ferro D, Angelico F, Del Ben M.
    Nutrients; 2022 Mar 08; 14(6):. PubMed ID: 35334784
    [Abstract] [Full Text] [Related]

  • 16. Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose.
    Tian H, Fang Y, Liu W, Wang J, Zhao J, Tang H, Yin Y, Hu Y, Peng J.
    J Ethnopharmacol; 2023 Jan 30; 301():115806. PubMed ID: 36216198
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction.
    Gutierrez JA, Liu W, Perez S, Xing G, Sonnenberg G, Kou K, Blatnik M, Allen R, Weng Y, Vera NB, Chidsey K, Bergman A, Somayaji V, Crowley C, Clasquin MF, Nigam A, Fulham MA, Erion DM, Ross TT, Esler WP, Magee TV, Pfefferkorn JA, Bence KK, Birnbaum MJ, Tesz GJ.
    Mol Metab; 2021 Jun 30; 48():101196. PubMed ID: 33667726
    [Abstract] [Full Text] [Related]

  • 18. Dietary sugar restriction reduces hepatic de novo lipogenesis in boys with fatty liver disease.
    Chung ST, Magge SN.
    J Clin Invest; 2021 Dec 15; 131(24):. PubMed ID: 34907906
    [Abstract] [Full Text] [Related]

  • 19. Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease.
    Paglialunga S, Dehn CA.
    Lipids Health Dis; 2016 Sep 17; 15(1):159. PubMed ID: 27640119
    [Abstract] [Full Text] [Related]

  • 20. Similarities and interactions between the ageing process and high chronic intake of added sugars.
    Gatineau E, Polakof S, Dardevet D, Mosoni L.
    Nutr Res Rev; 2017 Dec 17; 30(2):191-207. PubMed ID: 28511733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.